Search research articles
Contact Us
Filters
Showing results (61-70 of 72) with videos related to
Page
of 8
Sort By:
Biomed Research International
|
October 6, 2015
MicroRNA181a Is Overexpressed in T-Cell Leukemia/Lymphoma and Related to Chemoresistance
Zi-Xun Yan, Zhong Zheng, Wen Xue, et al.
Cell Death & Disease
|
March 26, 2021
A novel lncRNA TCLlnc1 promotes peripheral T cell lymphoma progression through acting as a modular scaffold of HNRNPD and YBX1 complexes
Ping Zhao, Meng-Meng Ji, Ying Fang, et al.
Nature Communications
|
June 18, 2024
Cholesterol efflux from C1QB-expressing macrophages is associated with resistance to chimeric antigen receptor T cell therapy in primary refractory diffuse large B cell lymphoma
Zi-Xun Yan, Yan Dong, Niu Qiao, et al.
Frontiers in Microbiology
|
October 16, 2023
Biocontrol of bacterial wilt disease in tomato using <i>Bacillus subtilis</i> strain R31
Yunhao Sun, Yutong Su, Zhen Meng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 25, 2019
Clinical Efficacy and Tumor Microenvironment Influence in a Dose-Escalation Study of Anti-CD19 Chimeric Antigen Receptor T Cells in Refractory B-Cell Non-Hodgkin's Lymphoma
Zi-Xun Yan, Li Li, Wen Wang, et al.
Plant Disease
|
August 19, 2023
Pathogen Profile of <i>Klebsiella variicola</i>, the Causative Agent of Banana Sheath Rot
Yunhao Sun, Chuanyuan Zheng, Jianuan Zhou, et al.
Insects
|
February 26, 2025
Formulation of Entomopathogenic Nematodes for Above-Ground Use Against Tomato Leaf Miner, <i>Phthorimaea absoluta</i>
Bancy W Waweru, Joelle N Kajuga, Athanase Hategekimana, et al.
Scientific Reports
|
August 9, 2017
JAM-A overexpression is related to disease progression in diffuse large B-cell lymphoma and downregulated by lenalidomide
Peng-Peng Xu, Yi-Feng Sun, Ying Fang, et al.
Biomarker Research
|
September 13, 2024
18F-FDG PET/CT metrics-based stratification of large B-cell lymphoma receiving CAR-T cell therapy: immunosuppressive tumor microenvironment as a negative prognostic indicator in patients with high tumor burden
Ling-Shuang Sheng, Rong Shen, Zi-Xun Yan, et al.
Genome Medicine
|
May 1, 2020
CEOP/IVE/GDP alternating regimen compared with CEOP as the first-line therapy for newly diagnosed patients with peripheral T cell lymphoma: results from a phase 2, multicenter, randomized, controlled clinical trial
Ming-Ci Cai, Shu Cheng, Xin Wang, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 72) with videos related to
Sort By:
Page
of 8
Biomed Research International
|
October 6, 2015
MicroRNA181a Is Overexpressed in T-Cell Leukemia/Lymphoma and Related to Chemoresistance
Zi-Xun Yan, Zhong Zheng, Wen Xue, et al.
Cell Death & Disease
|
March 26, 2021
A novel lncRNA TCLlnc1 promotes peripheral T cell lymphoma progression through acting as a modular scaffold of HNRNPD and YBX1 complexes
Ping Zhao, Meng-Meng Ji, Ying Fang, et al.
Nature Communications
|
June 18, 2024
Cholesterol efflux from C1QB-expressing macrophages is associated with resistance to chimeric antigen receptor T cell therapy in primary refractory diffuse large B cell lymphoma
Zi-Xun Yan, Yan Dong, Niu Qiao, et al.
Frontiers in Microbiology
|
October 16, 2023
Biocontrol of bacterial wilt disease in tomato using <i>Bacillus subtilis</i> strain R31
Yunhao Sun, Yutong Su, Zhen Meng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 25, 2019
Clinical Efficacy and Tumor Microenvironment Influence in a Dose-Escalation Study of Anti-CD19 Chimeric Antigen Receptor T Cells in Refractory B-Cell Non-Hodgkin's Lymphoma
Zi-Xun Yan, Li Li, Wen Wang, et al.
Plant Disease
|
August 19, 2023
Pathogen Profile of <i>Klebsiella variicola</i>, the Causative Agent of Banana Sheath Rot
Yunhao Sun, Chuanyuan Zheng, Jianuan Zhou, et al.
Insects
|
February 26, 2025
Formulation of Entomopathogenic Nematodes for Above-Ground Use Against Tomato Leaf Miner, <i>Phthorimaea absoluta</i>
Bancy W Waweru, Joelle N Kajuga, Athanase Hategekimana, et al.
Scientific Reports
|
August 9, 2017
JAM-A overexpression is related to disease progression in diffuse large B-cell lymphoma and downregulated by lenalidomide
Peng-Peng Xu, Yi-Feng Sun, Ying Fang, et al.
Biomarker Research
|
September 13, 2024
18F-FDG PET/CT metrics-based stratification of large B-cell lymphoma receiving CAR-T cell therapy: immunosuppressive tumor microenvironment as a negative prognostic indicator in patients with high tumor burden
Ling-Shuang Sheng, Rong Shen, Zi-Xun Yan, et al.
Genome Medicine
|
May 1, 2020
CEOP/IVE/GDP alternating regimen compared with CEOP as the first-line therapy for newly diagnosed patients with peripheral T cell lymphoma: results from a phase 2, multicenter, randomized, controlled clinical trial
Ming-Ci Cai, Shu Cheng, Xin Wang, et al.
Page
of 8